Q32 Bio (QTTB) FCF Margin (2018 - 2023)
Q32 Bio (QTTB) recorded quarterly FCF Margin of 787.87% in Q4 2023, down 8.98% quarter-over-quarter from 865.63% in Q3 2023, and up 418039.0% on a YoY basis from N/an in Q4 2022.
Q32 Bio (QTTB) FCF Margin (2018 - 2023) Analysis & Trends
Q32 Bio's FCF Margin history runs 6 years deep, the most recent figure standing at 787.87% for Q4 2023.
- In Q4 2023, FCF Margin rose 418039.0% year-over-year to 787.87%; the TTM figure through Sep 2024 stood at 4970.88% (up 537001.0% YoY), while the FY2025 annual figure was 64.21%, changed N/A from the prior year.
- FCF Margin was 787.87% for Q4 2023 at Q32 Bio, down from 865.63% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 865.63% in Q3 2023 to a low of 8572.22% in Q1 2019.
- Historically, FCF Margin has averaged 2979.2% across 5 years, with a median of 3251.0% in 2022.
- The sharpest annual moves came in 2019 and 2021: FCF Margin sank 759162 bps in 2019, then jumped 435990 bps in 2021.
- A 5-year view of FCF Margin shows it stood at 4636.94% in 2019, then surged by 80 bps to 912.65% in 2020, then plunged by 319 bps to 3820.07% in 2021, then increased by 11 bps to 3392.52% in 2022, then soared by 123 bps to 787.87% in 2023.
- The last three FCF Margin figures came in at 787.87% (Q4 2023), 865.63% (Q3 2023), and 360.62% (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Q32 Bio | 167.59 Mn | 116.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 787.87% |
| Sep 30, 2023 | 865.63% |
| Jun 30, 2023 | -360.62% |
| Mar 31, 2023 | -424.19% |
| Dec 31, 2022 | -3,392.52% |
| Sep 30, 2022 | -3,109.48% |
| Jun 30, 2022 | -3,997.13% |
| Mar 31, 2022 | -3,833.29% |
| Dec 31, 2021 | -3,820.07% |
| Sep 30, 2021 | -1,510.26% |
| Jun 30, 2021 | -1,069.41% |
| Mar 31, 2021 | -104.56% |
| Dec 31, 2020 | -912.65% |
| Sep 30, 2020 | -5,122.40% |
| Jun 30, 2020 | -5,326.81% |
| Mar 31, 2020 | -4,464.46% |
| Dec 31, 2019 | -4,636.94% |
| Sep 30, 2019 | -2,217.91% |
| Jun 30, 2019 | -8,362.50% |
| Mar 31, 2019 | -8,572.22% |